Cornerstone Capital Management Holdings’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
$341K Sell
15,627
-11,400
-42% -$249K ﹤0.01% 1065
2017
Q3
$1.11M Buy
27,027
+9,800
+57% +$401K 0.01% 907
2017
Q2
$518K Buy
17,227
+494
+3% +$14.9K ﹤0.01% 1031
2017
Q1
$604K Sell
16,733
-32,865
-66% -$1.19M ﹤0.01% 1023
2016
Q4
$2.48M Buy
49,598
+525
+1% +$26.3K 0.02% 674
2016
Q3
$2.58M Sell
49,073
-82,425
-63% -$4.33M 0.02% 677
2016
Q2
$5.44M Buy
131,498
+50,100
+62% +$2.07M 0.04% 430
2016
Q1
$3.31M Buy
81,398
+79,325
+3,827% +$3.22M 0.03% 583
2015
Q4
$86K Sell
2,073
-327
-14% -$13.6K ﹤0.01% 1327
2015
Q3
$37K Sell
2,400
-4,900
-67% -$75.5K ﹤0.01% 1434
2015
Q2
$182K Buy
7,300
+2,100
+40% +$52.4K ﹤0.01% 1212
2015
Q1
$119K Buy
+5,200
New +$119K ﹤0.01% 1250
2014
Q4
Sell
-3,000
Closed -$35K 1344
2014
Q3
$35K Buy
+3,000
New +$35K ﹤0.01% 1228